Not a good buy right now: price (15.25) is pressing into near-term resistance (R1 ~15.284) while short-term momentum looks stretched (RSI_6 ~73).
Trend is bullish, but without Intellectia signals and with earnings approaching (2026-02-12 pre-market), the risk/reward for an impatient entry is not attractive at this exact level.
If it cleanly breaks and holds above ~15.30, upside toward ~15.77 (R2) becomes more realistic; as-is, it’s better categorized as a hold rather than a buy-now.
Levels to watch: Support S1 ~13.718; resistance R1 ~15.284 then R2 ~15.768.
Pattern-based forward odds provided: modest positive bias (next month +4.86% probability outcome), but not a high-conviction edge at current resistance.
Positive Catalysts
Analyst stance remains constructive: Roth Capital reiterated Buy and raised PT to $16.50 (latest noted update: 2025-11-26).
Technical trend is bullish (stacked moving averages; positive MACD).
Dividend declared ($0.025 quarterly; ex-div 2026-02-19), supportive for sentiment.
Revenue growth was very strong in 2025/Q3 (+79.59% YoY), indicating strong top-line momentum.
Upcoming earnings (2026-02-12 pre-market) can act as a catalyst if profitability rebounds toward expectations (EPS est. 0.25).
Neutral/Negative Catalysts
and RSI_6 is elevated (~73), making the entry timing less favorable right now.
Financial Performance
Latest quarter provided: 2025/Q3
Revenue: 471.325M, +79.59% YoY (strong growth).
Net income: 1.206M, -71.97% YoY (sharp decline).
EPS: 0.02, -66.67% YoY.
Gross margin: 18.28%, down -6.59% YoY.
Takeaway: strong top-line acceleration, but deteriorating margins/profitability—growth quality is currently mixed.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Most recent noted action (2025-11-26): Roth Capital raised price target to $16.50 from $16 and maintained a Buy.
Wall Street pro view (from provided coverage):
Pros: better-than-expected margins vs expectations in that quarter, adjusted EBITDA beat, order intake improving, North America strength.
Cons: legacy Shyft softness cited (though improving late Q3), and the broader profitability trend (per financial snapshot) is currently a concern.
Wall Street analysts forecast AEBI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AEBI is 15.75 USD with a low forecast of 15 USD and a high forecast of 16.5 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Analyst Rating
Wall Street analysts forecast AEBI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AEBI is 15.75 USD with a low forecast of 15 USD and a high forecast of 16.5 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 14.610
Low
15
Averages
15.75
High
16.5
Current: 14.610
Low
15
Averages
15.75
High
16.5
Roth Capital
NULL -> Buy
maintain
$16
AI Analysis
2025-11-26
Reason
Roth Capital
Price Target
$16
AI Analysis
2025-11-26
maintain
NULL -> Buy
Reason
Roth Capital raised the firm's price target on Aebi Schmidt to $16.50 from $16 and keeps a Buy rating on the shares. The company delivered a sound Q3, with better-than-expected margins driving an adjusted EBITDA beat despite legacy Shyft softness, the analyst tells investors in a research note. The management cited order intake that appears to be picking up across the business, with strong growth in North America bolstered by significant strength in legacy Shyft walk-in-van orders that ramped toward the end of Q3, the firm added.
BTIG
Neutral
initiated
2025-07-18
Reason
BTIG
Price Target
2025-07-18
initiated
Neutral
Reason
BTIG initiated coverage of Aebi Schmidt with a Neutral rating and no price target following the close of the company's merger with the Shyft Group. Aebi is well positioned to manage the uncertain macro backdrop given its municipal and other government-backed business, which should provide some stability, the analyst tells investors in a research note. BTIG likes the company's portfolio but is on the sidelines due to macro uncertainty in both the U.S. and Europe.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for AEBI
